BCG enters tumour cells through phagocytosis to stimulate the production of cellular immune factors such as MCP‐1, MDC, TNF and IL‐10, resulting in the weakening of tumour cell differentiation or stopping the replication cycle. The gene discussed is CCL2; the disease is neoplasm.